Search Results 931-940 of 16663 for mesenteric fat and ibd

  1. A Study to Compare Effectiveness of Biofeedback, Nerve Stimulation, and Injectable Bulking Agents for Fecal Incontinence Treatment - Mayo Clinic

    Established diagnosis of inflammatory bowel disease. Intestinal stoma present. History of pelvic radiation within previous 12 months or presence of active ...

  2. Publications - Mike L. Wells, M.D. - Mayo Clinic

    Dhillon P, Naidu M, Olson MC, VanBuren WM, Sheedy SP, Wells ML, Fidler JL, Heiken JP, Venkatesh SK, Kelm ZS. Diffusely Infiltrative Small Bowel Disease.

  3. SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) - Mayo Clinic

    History of inflammatory bowel disease (ulcerative colitis, Crohn's disease, microscopic colitis) with diarrhea believed to be caused by active inflammatory ...

  4. Understanding the Role of Gut Microbiome in Pathogenesis of Clostridioides Difficile Infection

    Gut Microbiome Lab of Purna Kashyap at Mayo Clinic: Studying how natural variation in individual gut microbiomes relates to risk of C. difficile infection.

  5. How fit are you? See how you measure up - Mayo Clinic

    Body composition: Body mass index. Your body mass index (BMI) shows whether you have a healthy amount of body fat. You can find your BMI with a ...

  6. Liver Disease Clinical Trials

    The primary aim of this study is to use an MRI-based Muscle Assessment Score (MAsS), which includes both muscle volume and fat infiltration, at the transplant ...

  7. Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel ...

  8. Untitled

    O. I think this is really a time when engagement with bowel cancer screening we could really push colorectal cancer down to an absolute minimum. DeeDee Stiepan ...

  9. NAFLD and NASH research update - Mayo Clinic

    Mayo Clinic researchers are exploring several new treatment options for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

  10. Treating Visceral Sensation and Chronic Abdominal Pain with Rimegepant - Mayo Clinic

    The primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS. Participation ...